DCM Shriram Fine Chemicals: Akshay Dhar Acquires Shares Under SEBI Regulations
Akshay Dhar completed a strategic share acquisition in DCM Shriram Fine Chemicals Ltd., acquiring 252706 shares (0.29%) through off-market transfer from Tilak Dhar & Sons on March 30, 2026. The transaction increased his shareholding from 1274060 shares (1.46%) to 1526766 shares (1.76%), executed as HUF asset distribution under SEBI regulatory exemption 10(1)(a)(i) with proper compliance disclosures filed.
*this image is generated using AI for illustrative purposes only.
Akshay Dhar has executed a significant share acquisition in DCM Shriram Fine Chemicals Ltd., filing the required disclosure under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. The transaction, completed through an off-market transfer, represents a strategic increase in his equity position within the specialty chemicals company.
Transaction Overview
The share acquisition was executed under specific regulatory parameters that demonstrate compliance with SEBI guidelines:
| Parameter: | Details |
|---|---|
| Shares Acquired: | 252706 |
| Transaction Value (%): | 0.29% of total share capital |
| Transaction Mode: | Off-market transfer |
| Transaction Date: | March 30, 2026 |
| Seller/Transferor: | Tilak Dhar & Sons |
| Regulatory Exemption: | 10(1)(a)(i) |
Shareholding Changes
The transaction resulted in a notable change in Dhar's ownership structure within DCM Shriram Fine Chemicals:
| Holding Period: | Number of Shares | Percentage (%) |
|---|---|---|
| Before Acquisition: | 1274060 | 1.46 |
| Shares Acquired: | 252706 | 0.29 |
| After Acquisition: | 1526766 | 1.76 |
The acquisition represents approximately a 20% increase in Dhar's absolute shareholding, while his percentage ownership increased from 1.46% to 1.76% of the company's total voting capital.
Regulatory Compliance Framework
The transaction was structured as a distribution of assets through partition of HUF (Hindu Undivided Family), which qualifies for exemption under SEBI regulations. Key compliance aspects include:
| Compliance Aspect: | Details |
|---|---|
| Initial Disclosure Date: | March 21, 2026 |
| Transaction Completion: | March 30, 2026 |
| Regulation Applied: | 10(6) - Exempted Acquisition Report |
| Exchange Listing: | NSE (Symbol: DSFCL) & BSE (Scrip: 544703) |
Corporate Structure Impact
The share transfer occurred between related entities within the promoter group structure, specifically from Tilak Dhar & Sons to Akshay Dhar. This internal reorganization maintains the overall promoter group holding while redistributing ownership among family entities. The transaction was executed without any monetary consideration, being structured as an asset distribution through HUF partition.
DCM Shriram Fine Chemicals Ltd. continues to maintain its stable capital structure, with shares listed on both NSE and BSE exchanges. The company operates under ISIN code INE00FMO1015, and the transaction adheres to all regulatory disclosure requirements under SEBI's substantial acquisition framework.
Will this internal shareholding restructuring signal potential changes in DCM Shriram Fine Chemicals' strategic direction or management approach?
How might this increased individual stake by Akshay Dhar impact the company's future capital allocation decisions and dividend policy?
Could this HUF partition be part of a broader succession planning strategy within the promoter group that may affect corporate governance?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
